Watch CBS News

Booster Dose

1021-cbsn-avx-820038-640x360.jpg

Virologist talks mixing COVID-19 vaccines

The Centers for Disease Control and Prevention will review the Food and Drug Administrations's decision to approve booster shots for the Moderna and Johnson and Johnson vaccines, which would allow more than 15 million Americans to get a booster shot. Dr. Dan Barouch, a physician at Beth Israel Deaconess Medical Center in Boston and director at the Center For Virology and Vaccine Research who helped develop the Johnson & Johnson COVID-19 vaccine, joins CBSN to discuss mixing and matching doses.

cbsn-fusion-fda-authorizes-jj-and-moderna-booster-shots-ahead-of-cdc-panel-meeting-thumbnail-819618-640x360.jpg

FDA authorizes J&J and Moderna booster shots

The FDA has authorized COVID-19 booster shots for some recipients of the Johnson and Johnson and Moderna vaccines. But as Nikki Battiste reports, the agency says eligible Americans can get any brand of booster, regardless of the shot they initially got. Then, Dr. Elizabeth Clayborne, an emergency physician and adjunct professor of emergency medicine at the University of Maryland School of Medicine, joins CBSN's Lana Zak with her analysis.

cbsn-fusion-fda-advisory-panel-unanimously-votes-to-recommend-johnson-and-johnson-booster-shot-thumbnail-816453-640x360.jpg

FDA panel recommends J&J booster shot

The FDA advisory panel unanimously voted to recommend the Johnson & Johnson booster shot on Friday. It comes a day after the same panel made the recommendation for a third Moderna shot. President Biden says full FDA and CDC approval for both boosters could come as early as next week. CBS News reporter Max Bayer and John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, join CBSN's Tanya Rivero to discuss the FDA panel's vote.

1014-cbsn-wgt-wgv-816058-640x360.jpg

FDA panel endorses Moderna booster for some

An FDA advisory panel unanimously voted to recommend Moderna's COVID-19 vaccine booster six months after initial vaccination for vulnerable Americans. Those included in the recommendation are people ages 65 and older, adults with underlying health conditions and those with an increased risk of contracting the virus due to their job. Dr. Shad Marvasti, the director of public health, prevention and promotion and an associate professor at the University of Arizona College of Medicine Phoenix, joins CBSN to discuss the latest.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue